Stock CE CELANESE CORPORATION
Add to a list
To use this feature you must be a member
Log inSign up

Financials Celanese Corporation

Equities

CE

US1508701034

Specialty Chemicals

Market Closed - Nyse
Other stock markets
 04:00:02 2024-06-06 pm EDT 		5-day change 1st Jan Change
147.2 USD +0.16% Intraday chart for Celanese Corporation -2.72% -5.26%
Jun. 03 Alembic Adjusts Price Target on Celanese to $165 From $160 MT
May. 17 Piper Sandler Adjusts Price Target on Celanese to $180 From $170 MT

Valuation

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Capitalization 1 14,882 15,189 18,297 11,086 16,913 16,077 - -
Enterprise Value (EV) 1 18,324 17,957 21,728 24,257 28,792 27,006 25,593 24,392
P/E ratio 18 x 7.76 x 9.97 x 5.9 x 8.67 x 14.2 x 11.2 x 10.8 x
Yield 1.95% 1.91% 1.62% 2.68% 1.8% 1.91% 1.97% 2.12%
Capitalization / Revenue 2.36 x 2.69 x 2.14 x 1.15 x 1.55 x 1.47 x 1.39 x 1.33 x
EV / Revenue 2.91 x 3.18 x 2.55 x 2.51 x 2.63 x 2.47 x 2.21 x 2.02 x
EV / EBITDA 10.2 x 12.2 x 7.66 x 9.27 x 11.8 x 9.96 x 8.61 x 7.9 x
EV / FCF 16.9 x 18.3 x 16.8 x 19 x 21.8 x 19.7 x 16.9 x 13.7 x
FCF Yield 5.92% 5.45% 5.94% 5.26% 4.58% 5.07% 5.92% 7.28%
Price to Book 5.91 x 4.34 x 4.33 x 1.97 x 2.4 x 2.03 x 1.79 x 1.58 x
Nbr of stocks (in thousands) 120,874 116,895 108,871 108,428 108,855 109,220 - -
Reference price 2 123.1 129.9 168.1 102.2 155.4 147.2 147.2 147.2
Announcement Date 1/30/20 1/28/21 1/27/22 2/23/23 2/20/24 - - -
1USD in Million2USD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net sales 1 6,297 5,655 8,537 9,673 10,940 10,952 11,576 12,094
EBITDA 1 1,805 1,475 2,835 2,617 2,444 2,712 2,972 3,087
EBIT 1 1,476 1,131 2,473 2,171 1,753 1,999 2,259 2,415
Operating Margin 23.44% 20% 28.97% 22.44% 16.02% 18.26% 19.51% 19.97%
Earnings before Tax (EBT) 1 988 2,251 2,248 1,421 1,183 1,308 1,727 1,509
Net income 1 852 1,985 1,890 1,894 1,960 1,133 1,490 1,496
Net margin 13.53% 35.1% 22.14% 19.58% 17.92% 10.34% 12.87% 12.37%
EPS 2 6.840 16.75 16.86 17.34 17.92 10.39 13.11 13.60
Free Cash Flow 1 1,084 979 1,290 1,276 1,320 1,368 1,514 1,775
FCF margin 17.21% 17.31% 15.11% 13.19% 12.07% 12.49% 13.08% 14.68%
FCF Conversion (EBITDA) 60.06% 66.37% 45.5% 48.76% 54.01% 50.46% 50.95% 57.49%
FCF Conversion (Net income) 127.23% 49.32% 68.25% 67.37% 67.35% 120.77% 101.62% 118.66%
Dividend per Share 2 2.400 2.480 2.720 2.740 2.800 2.813 2.899 3.118
Announcement Date 1/30/20 1/28/21 1/27/22 2/23/23 2/20/24 - - -
1USD in Million2USD
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1 2025 Q2
Net sales 1 2,275 2,538 2,486 2,301 2,348 2,853 2,795 2,723 2,569 2,611 2,801 2,834 2,699 2,824 3,014
EBITDA 1 745 813 744 607 453 596 616 624 608 583 688.3 742.7 707.6 706.7 767.8
EBIT 1 652 713 646 510 302 424 444 451 434 407 509.6 561.3 529.2 541.1 604.1
Operating Margin 28.66% 28.09% 25.99% 22.16% 12.86% 14.86% 15.89% 16.56% 16.89% 15.59% 18.19% 19.8% 19.61% 19.16% 20.04%
Earnings before Tax (EBT) 1 557 616 554 321 -70 121 216 714 132 157 350 421 393.7 406 459
Net income 1 524 502 434 191 767 91 219 951 698 121 304.8 356.8 334 349.5 395.5
Net margin 23.03% 19.78% 17.46% 8.3% 32.67% 3.19% 7.84% 34.92% 27.17% 4.63% 10.88% 12.59% 12.38% 12.38% 13.12%
EPS 2 4.790 4.610 3.980 1.750 7.030 0.8300 2.000 8.690 6.370 1.100 2.790 3.296 3.089 3.200 3.625
Dividend per Share 2 0.6800 0.6800 0.6800 0.6800 0.7000 0.7000 0.7000 - 0.7000 - 0.7083 0.7083 0.7200 0.7167 0.7233
Announcement Date 1/27/22 4/28/22 7/28/22 11/3/22 2/23/23 5/9/23 8/7/23 11/6/23 2/20/24 5/8/24 - - - - -
1USD in Million2USD
Estimates

Balance Sheet Analysis

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net Debt 1 3,442 2,768 3,431 13,171 11,879 10,929 9,516 8,315
Net Cash position 1 - - - - - - - -
Leverage (Debt/EBITDA) 1.907 x 1.877 x 1.21 x 5.033 x 4.86 x 4.03 x 3.202 x 2.693 x
Free Cash Flow 1 1,084 979 1,290 1,276 1,320 1,368 1,514 1,775
ROE (net income / shareholders' equity) 43.3% 30% 52.7% 35.3% 15.3% 16.7% 17.8% 17.7%
ROA (Net income/ Total Assets) 9.07% 19.5% 16.5% 9.07% 3.69% 4.74% 5.66% 6.27%
Assets 1 9,395 10,193 11,442 20,888 53,086 23,921 26,321 23,869
Book Value Per Share 2 20.80 29.90 38.80 52.00 64.80 72.50 82.20 93.30
Cash Flow per Share 2 11.70 11.30 15.70 16.70 17.40 16.10 18.30 21.60
Capex 1 370 364 467 543 568 436 496 540
Capex / Sales 5.88% 6.44% 5.47% 5.61% 5.19% 3.98% 4.29% 4.46%
Announcement Date 1/30/20 1/28/21 1/27/22 2/23/23 2/20/24 - - -
1USD in Million2USD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Ratings for Celanese Corporation

Trading Rating
Investor Rating
ESG Refinitiv
B+
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
21
Last Close Price
147.2 USD
Average target price
166.1 USD
Spread / Average Target
+12.87%
Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Specialty Chemicals

1st Jan change Capi.
CELANESE CORPORATION Stock Celanese Corporation
-5.26% 16.05B
ECOLAB INC. Stock Ecolab Inc.
+21.26% 68.31B
SIKA AG Stock Sika AG
-0.07% 48.94B
GIVAUDAN SA Stock Givaudan SA
+24.11% 44.65B
FUJIFILM HOLDINGS CORPORATION Stock Fujifilm Holdings Corporation
+29.45% 27.81B
EMS-CHEMIE HOLDING AG Stock EMS-CHEMIE HOLDING AG
+7.64% 19.14B
SYMRISE AG Stock Symrise AG
+10.10% 16.76B
POSCO FUTURE M CO., LTD. Stock Posco Future M Co., Ltd.
-23.26% 15.55B
ALBEMARLE CORPORATION Stock Albemarle Corporation
-18.20% 13.94B
SOCIEDAD QUÍMICA Y MINERA DE CHILE S.A. Stock Sociedad Química y Minera de Chile S.A.
-21.84% 13.38B
Other Specialty Chemicals
  1. Stock Market
  2. Equities
  3. CE Stock
  4. Financials Celanese Corporation